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Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 
(CADASIL) is thought to be a pure genetic form of subcortical vascular cognitive impairment (SVCI). 
The aim of this study was to compare white matter integrity and cortical thickness between typical 
CADASIL, a genetic form, and two sporadic forms of SVCI (with NOTCH3 and without NOTCH3 variants). 
We enrolled typical CADASIL patients (N = 11) and SVCI patients [with NOTCH3 variants (N = 15), 
without NOTCH3 variants (N = 101)]. To adjust the age difference, which reflects the known difference 
in clinical and radiologic courses between typical CADASIL patients and SVCI patients, we constructed 
a W-score of measurement for diffusion tensor image and cortical thickness. Typical CADASIL patients 
showed more frequent white matter hyperintensities in the bilateral posterior temporal region 
compared to SVCI patients (p < 0.001, uncorrected). We found that SVCI patients, regardless of the 
presence of NOTCH3 variants, showed significantly greater microstructural alterations (W-score, 
p < 0.05, FWE-corrected) and cortical thinning (W-score, p < 0.05, FDR-corrected) than typical CADASIL 
patients. In this study, typical CADASIL and SVCI showed distinct anatomic vulnerabilities in the cortical 
and subcortical structures. However, there was no difference between SVCI with NOTCH3 variants and 
SVCI without NOTCH3 variants.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is 
characterized by extensive cerebral small vessel disease (CSVD) and cognitive impairments in later life. CADASIL 
therefore refers to a pure genetic form of subcortical vascular cognitive impairment (SVCI)1. CADASIL results 
from mutations in NOTCH3, which is predominantly expressed in vascular smooth muscle cells, preferentially in 
small arteries. Mutant NOTCH3 receptors have been proposed to induce the deposition of granular osmiophilic 
material (GOM) in vascular smooth muscle cells in the small arterioles. This leads to ischemia in the white matter, 
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eventually resulting in CSVD2. On the other hand, sporadic SVCI results from vascular risk factors. Specifically, 
hypertension and diabetes can cause arteriosclerosis in small vessels, which then leads to CSVD, including white 
matter hyperintensities (WMH) and lacunes on magnetic resonance imaging (MRI)3.
Previous studies have shown that genetic forms of dementia have distinct features compared to sporadic 
forms. Specifically, autosomal dominant Alzheimer’s disease (AD) starts earlier and deteriorates faster than spo-
radic AD, although autosomal dominant AD and sporadic AD share a common pathophysiological cascade4,5. 
Previous studies have also shown that autosomal dominant AD results in cortical thinning in the parietal region, 
in contrast to sporadic AD6. Autosomal dominant AD also results in increased amyloid uptake, predominantly 
in the striatum7–9. Likewise, CADASIL and SVCI may show distinct distributions of WMH, although CADASIL 
and SVCI share the same CSVD MRI markers, including WMH and lacunes10.
CADASIL displays characteristic abnormalities in the anterior parts of the temporal lobes and the external 
capsule11–13. Anterior pole lesions have high sensitivity and specificity, while external capsule lesions have high 
sensitivity but low specificity1. However, considering that the anterior part of the temporal region is less com-
monly involved in Asian patients with CADASIL compared to European patients with CADASIL14,15, studies 
in Asian patients of the topographical differences of WMH between CADASIL and SVCI would be worthwhile. 
Previous neuroimaging studies have shown that patients with typical CADASIL and SVCI exhibit white matter 
microstructural changes16–18 and cortical thinning compared to healthy controls19–21. In terms of white matter 
microstructural changes, a study using tract-based spatial statistics (TBSS) demonstrated that CADASIL patients 
showed decreased fractional anisotropy (FA) and increased mean diffusivity (MD) values in extensive symmet-
ric areas compared to healthy controls16. Also, our previous diffusion tensor imaging (DTI) studies revealed 
that SVCI patients showed decreased FA values in many brain regions relative to healthy controls17,18. In terms 
of cortical thinning, a previous study showed that the cortical thickness of CADASIL patients was not signifi-
cantly different from that of the normal control group, but the T2* as measured by 7 Tesla MRI was significantly 
increased compared to that of the healthy control group22. Our studies showed that SVCI patients exhibited cor-
tical thinning in the frontal, perisylvian, basal temporal, and posterior cingulate regions compared with healthy 
controls18,20,21. However, CADASIL and SVCI have not been directly and comprehensively compared.
We previously showed that approximately 13% of all consecutively recruited SVCI patients had NOTCH3 
variants23, although they did not meet the clinical criteria for CADASIL. There were no differences in the clin-
ical features between SVCI patients with versus without NOTCH3 variants, while CADASIL patients did show 
distinctive clinical features compared to SVCI patients with NOTCH3 variants. A reasonable hypothesis is thus 
that CADASIL patients show different WMH distributions, different microstructural change topographies, and 
different patterns of cortical thinning compared to SVCI patients (with and without NOTCH3 variants), while 
SVCI patients with NOTCH3 variants and patients without NOTCH3 variants do not show differences in these 
neuroimaging features. However, little is known regarding the neuroimaging features of CADASIL patients, SVCI 
with NOTCH3 variants, and SVCI without NOTCH3 variants (genetic and sporadic types), which share similar 
phenotypes. In this regard, we tested and confirmed our new hypothesis that there are differences in neuroimag-
ing features among these three groups.
SVCI patients often showed combined AD pathologies. Our previous study found that 64% to 69% of the SVCI 
patients had no amyloid plaque pathology, but 31% to 36% of the SVCI patients had amyloid plaque pathology 
using [11C] Pittsburgh compound B (PiB) positron emission tomography (PET) scanning24–26. There were some 
differences between SVCI with amyloid plaque pathology and SVCI without amyloid amyloid plaque pathology 
in terms of age, Mini-Mental State Examination (MMSE) score, number of lacunae, and visual ratings of medial 
temporal lobe atrophy (MTA)24. SVCI patients without amyloid plaque pathology were younger and had a greater 
number of lacunes26. The proportion of APOE e4 carriers was higher in SVCI patients with amyloid plaque 
pathology26. Therefore, amyloid plaque pathology should be considered when comparing CADASIL with SVCI.
The aim of this study was to compare white matter integrity and cortical thickness between CADASIL, a 
genetic form, and two sporadic forms of SVCI (with NOTCH3 and without NOTCH3 variants). SVCI patients 
also underwent [11C] PiB PET scanning that is known to have high specificity and sensitivity for detecting amy-
loid deposition27. In this study, we used the term “typical” CADASIL to distinguish it from SVCI groups with 
NOTCH3 variant genes. We hypothesized that typical CADASIL patients would exhibit more severe structural 
damages in the white matter and grey matter compared to SVCI patients (with NOTCH3 variants and SVCI 
patients without NOTCH3 variants), because genetic forms usually have more severe manifestations than spo-
radic forms of disease. We also hypothesized that cortical thickness and white matter integrity in SVCI patients 
with NOTCH3 variants would not be significantly different from those in SVCI patients without NOTCH3 var-
iants, considering that a previous study showed that NOTCH3 variants did not affect clinical features in SVCI 
patients23.
Results
Demographic characteristics of participants. The demographic data and clinical features of the patients 
are described in Table 1. The mean patient age was 57 ± 7 years in the typical CADASIL group, 72 ± 8 years in the 
SVCI with NOTCH3 variants group, and 74 ± 7 years in the SVCI without NOTCH3 variants group. Hypertension 
was significantly more frequent in the SVCI groups (with and without NOTCH3 variants) than in the typical 
CADASIL group. The rates of ischemic stroke occurrence were not significantly different among the typical 
CADASIL, SVCI with NOTCH3 variants, and SVCI without NOTCH3 variants groups. Two patients (13%) in 
the SVCI with NOTCH3 variants group were PiB positive, while 32 patients (32%) in the SVCI without NOTCH3 
variants group were PiB positive (Table 1).
Spatial distribution of WMH. Figure 1A shows the WMH frequency maps for each of the three groups, 
which can be used to visualize the spatial distributions of WMH. WMH was most prevalent in the periventricular 
www.nature.com/scientificreports/
3SCIENTIfIC RepoRts |           (2019) 9:787  | DOI:10.1038/s41598-018-36580-0
white matter around the frontal and posterior horns of the lateral ventricles in all three groups (typical CADASIL, 
SVCI with NOTCH3 variants, and SVCI without NOTCH3 variants). As shown in Fig. 1B, WMH was significantly 
more prevalent in the bilateral posterior temporal region in the typical CADASIL group compared to the two 
SVCI groups (with and without NOTCH3 variants) (p < 0.001, uncorrected). There was no significant difference 
between the two SVCI groups (with and without NOTCH3 variants).
Microstructural alterations on DTI. The W-score maps (Supplementary Fig. 1) of FA and MD showed 
diffuse microstructural alterations in all three groups [typical CADASIL, SVCI with NOTCH3 variants, and SVCI 
without NOTCH3 variants (Fig. 2A-1,2)]. The W-scores of the FA and MD maps are shown in Fig. 2B-1,2. Both 
SVCI groups [with NOTCH3 variants (Fig. 2B-1) and without NOTCH3 variants (Fig. 2B-2)] showed significantly 
decreased FA W-scores and significantly fewer MD-involved long white matter tracts in many brain regions, 
including the bilateral frontal lobe, temporal lobe, parietal lobes, transcallosal fibers, and brainstem, compared to 
the typical CADASIL group (p < 0.05, family-wise error rate [FWE]-corrected). However, there were no regions 
where the typical CADASIL patients showed more DTI measure abnormalities than the SVCI patients. There was 
no difference between the two SVCI groups (with and without NOTCH3 variants).
We next performed a sensitivity analysis for the amyloid-negative group to exclude the possibility that amyloid 
deposition affected the DTI results. The results confirmed that both SVCI groups (with and without NOTCH3 
variants) showed significantly decreased FA W-scores and significantly fewer MD-involved diffuse white matter 
tracts compared to the typical CADASIL group (p < 0.05, FWE-corrected, Supplementary Fig. 2). Additionally, 
we analyzed T-value maps for age-matched subjects to remove any potential effect of age on the DTI results. The 
W-score maps of the FA and MD t-values showed that the SVCI without NOTCH3 variants group had more dif-
fuse microstructural damage than the typical CADASIL group (Supplementary Fig. 3).
Topography of cortical thickness. Figure 3A shows the cortical thinning patterns in the three groups 
as assessed using the W-score. The cortical thickness W-score (Supplementary Fig. 1) for the SVCI without 
NOTCH3 variants group was significantly lower than that of the typical CADASIL group in multiple brain 
regions, including the bilateral dorsolateral region, the medial prefrontal region, the occipital region, and the right 
anterior and left inferior temporal regions (p < 0.05, false discovery rate [FDR]-corrected, Fig. 3B-2). The cortical 
thickness W-scores for the SVCI with NOTCH3 variants group showed a similar pattern of decrease compared to 
those of the typical CADASIL group; however, these differences were not significant (Fig. 3B-1). There were no 
regions where the typical CADASIL patients showed more decreased cortical thickness than the SVCI patients. 
There was also no difference between the two SVCI groups (with and without NOTCH3 variants).
We next performed a sensitivity analysis for the amyloid-negative group to exclude the possibility that amyloid 
deposition affected cortical thickness. The results confirmed that both SVCI groups (with and without NOTCH3 
variants) showed significantly decreased cortical atrophy compared to the typical CADASIL group; the pattern 
was the same as that of the main results [p < 0.05, false discovery rate (FDR)-corrected, Supplementary Fig. 4]. 
Another sensitivity analysis was performed with age-matched subjects to ensure that no aging-related effects on 
cortical thickness were confounding the results; the t-map is shown in Supplementary Fig. 5.
Discussion
In this study, we investigated spatial features of multimodal neuroimaging among well-characterized cohorts of 
typical CADASIL patients and SVCI patients with genetic biomarker data. We found that SVCI patients, regard-
less of the presence of NOTCH3 variants, showed significantly more microstructural alterations (Fig. 2) and cor-
tical thinning (Fig. 3) than typical CADASIL patients. However, these differences in neuroimaging features were 
not observed between the SVCI patients with NOTCH3 variants and those without NOTCH3 variants.
Typical 
CADASIL
SVCI
p value
With NOTCH3 
variants
Without NOTCH3 
variants
Subjects (number) 11 15 101
Age, mean ± SD (years) 57 ± 7 72 ± 8 74 ± 7 <0.001
Sex, female, N (%) 5 (45.5) 9 (60) 62 (61.4) 0.592
Education, mean ± SD (years) 12.2 ± 4.6 8.1 ± 5.1 9.0 ± 5.1 0.102
Hypertension (%) 2 (18.2) 13 (86.7) 77 (76.2) <0.001
Diabetes (%) 3 (27.3) 3 (20.0) 26 (25.7) 0.880
Hyperlipidemia (%) 3 (27.3) 9 (60.0) 30 (29.7) 0.061
Ischemic TIA/stroke (%) 5 (45.5) 4 (26.7) 23 (22.8) 0.256
MMSE, median (IQR) 28 (24–30) 27 (12–30) 25 (9–30) 0.024
PiB-positive (%) — 2 (13) 32 (32) 0.225
Table 1. Demographic and clinical features in the typical CADASIL, SVCI with NOTCH3 variants, and SVCI 
without NOTCH3 variants groups. CADASIL: cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy; IQR: interquartile range; MMSE: Mini-Mental State Examination; 
N: number; PiB: Pittsburgh compound B; SD: standard deviation; SVCI: subcortical vascular cognitive 
impairment; TIA: transient ischemic attack.
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Our first major finding was that typical CADASIL patients showed more frequent WMH in the bilateral poste-
rior temporal region compared to SVCI patients (Fig. 1). Previously, involvement of WMH in the anterior part of 
the temporal lobes was suggested to be highly indicative of typical CADASIL11–13, with a sensitivity and specificity 
of 95% and 80%, respectively. However, the reported frequencies of WMH involvement in the anterior temporal 
region have been lower in studies of Asian participants than in studies of Western participants. Previous studies 
of Asian participants reported that that 44.8% to 68.4% of all typical CADASIL patients had anterior temporal 
involvement15,23,28–30. Therefore, our findings suggest that Asian CADASIL patients often have WMH involvement 
in the posterior temporal region (54.5%) as well as in the anterior (54.2%) temporal region.
Our second major finding was that SVCI patients (with NOTCH3 and without NOTCH3 variants) had more 
microstructural alterations in the bilateral frontal lobe, temporal lobe, parietal lobes, anterior corpus callosum, 
and posterior corpus callosum than typical CADASIL patients (Fig. 2). However, our findings were not in line 
with a previous study that suggested that CADASIL patients showed more microstructural alterations than 
patients with small vessel disease31. We assumed that our SVCI patients may have more WMH burdens than 
the patients with small vessel disease included in the previous study because we included SVCI patients with 
high WMH load only, while the previous study included both low and high WMH load patients. Our suggestion 
could be supported by subgroup analysis of the previous study, which showed more microstructural alterations in 
patients with high WMH load compared to ones with low WMH load31. Additionally, we performed sensitivity 
analyses based on amyloid (−) SVCI patients to exclude the possibility that AD pathology might have affected 
microstructural alterations. Our previous study revealed that SVCI patients often showed combined AD patholo-
gies24. Our amyloid (−) SVCI patients also showed results similar to the original analyses (Supplementary Fig. 2). 
Therefore, unlike a previous study31, our findings suggested that sporadic patients with extensive CSVD might 
have more microstructural alterations than CADASIL patients.
Our third major finding was that the SVCI patients without NOTCH3 variants showed more cortical thinning 
in the bilateral dorsolateral region, the medial prefrontal region, the occipital region, and the right anterior and 
left inferior temporal regions compared to typical CADASIL patients (Fig. 3B-2). In Fig. 3B-1, the T-map shows 
Figure 1. WMH frequency maps of the three groups (A) and comparison of frequency maps between the 
typical CADASIL and SVCI groups (B). (A-1) Typical CADASIL patients show extensive WMH distributed 
throughout the periventricle, posterior temporal white matter, and anterior temporal white matter. (A-2,A-
3) SVCI patients with NOTCH3 variants and SVCI patients without NOTCH3 variants show similar WMH 
frequency maps. (B-1,B-2) Typical CADASIL patients show significantly more prevalent WMH distribution in 
the bilateral posterior temporal region compared to SVCI patients with NOTCH3 variants and SVCI patients 
without NOTCH3 variants (p < 0.001, uncorrected; the corresponding T-value is shown through the color bar.). 
CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; SVCI: 
subcortical vascular cognitive impairment; WMH: white matter hyperintensities.
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similar patterns of differences between the typical CADASIL and the SVCI patients with NOTCH3 variants. 
However, there was no significant difference between the two groups. This might be related to the small sample 
size of SVCI patients with NOTCH3 variants (N = 15). Previous studies have compared the cortical thickness of 
normal controls with that of CADASIL or SVCI patients. A previous study showed that, while the cortical thick-
ness of typical CADASIL patients was not significantly different from that of the normal control group, the T2* 
as measured by 7 Tesla MRI was significantly increased compared to that of the normal control group22. In our 
previous study, SVCI patients exhibited cortical thinning in the frontal, perisylvian, basal temporal, and posterior 
cingulate regions compared with normal controls18,20,21. However, the cortical thickness of typical CADASIL and 
SVCI patients has not been directly and comprehensively compared. In this study, direct comparisons revealed 
that patients with SVCI without NOTCH3 variants had more cortical thinning compared to patients with typical 
CADASIL. Furthermore, we performed sensitivity analyses based on amyloid (−) SVCI patients to exclude the 
possibility that AD pathology might have affected cortical thickness. Our amyloid (−) SVCI patients also showed 
that the SVCI patients without NOTCH3 variants showed more cortical thinning than typical CADASIL patients 
in patterns similar to the original analyses (Supplementary Fig. 4).
The reason SVCI patients have more abnormalities in their microstructural changes and cortical thinning 
than typical CADASIL patients remains unknown. Considering that genetic models such as familial Alzheimer’s 
disease generally have similar but more severe deterioration, both clinically and pathologically4,5,32, our find-
ings are unexpected. A possible explanation is that the SVCI patients were, on average, older than the typical 
CADASIL patients and had more coexistent AD pathologies. However, our sensitivity analyses excluded these 
Figure 2. FA and MD W-score maps of the three groups (A) and comparison of the W-score maps between the 
typical CADASIL and SVCI groups (B). (A-1) Red-yellow colors indicate low W-scores of FA value in typical 
CADASIL patients, SVCI patients with NOTCH3 variants, and SVCI patients without NOTCH3 variants, 
respectively, in reference to the cognitively normal participants. (A-2) Dark to light blue colors indicate higher 
W-scores of MD value in typical CADASIL patients, SVCI patients with NOTCH3 variants, and SVCI patients 
without NOTCH3 variants, respectively, in reference to the cognitively normal participants. (B-1,B-2) Red-
yellow colors indicate significantly lower W-scores of FA value in SVCI patients (with or without NOTCH3 
variants) compared to the typical CADASIL patients in several brain regions (i.e., white matter in the frontal 
and parietal lobes, periventricular white matter, temporal white matter, anterior corpus callosum, and posterior 
corpus callosum). Blue-light blue color indicates significantly higher W-scores of MD value in SVCI patients 
(with or without NOTCH3 variants) compared to the typical CADASIL patients in similar regions. These are 
inversely related to the FA values, suggesting that SVCI patients showed more DTI-measured abnormalities 
than the typical CADASIL patients (W-score, p < 0.05, FWE). However, there are no regions where the typical 
CADASIL patients showed more DTI-measured abnormalities than the SVCI patients. CADASIL: cerebral 
autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; FA: fractional anisotropy; 
MD: mean diffusivity; SVCI: subcortical vascular cognitive impairment.
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potential explanations. Our SVCI patients had significant vascular burden and cognitive impairments, which 
may limit the generalizability of our data to other populations. Further studies are needed to explain the different 
pathogenesis mechanisms driving typical CADASIL and SVCI.
Another noteworthy finding with respect to microstructural changes and cortical thickness was that NOTCH3 
variations did not affect WMH distribution or topography in the SVCI patients. Consistent with our finding, 
a previous study that assessed NOTCH3 variants revealed that only one of 39 variants was associated with an 
increased risk of ischemic stroke with small vessel disease subtype in Caucasians33. Another study found no asso-
ciation of any common variants in NOTCH3 with lacunar stroke or WMH volume in Caucasian patients with 
ischemic stroke34. In contrast, a study based on an Austrian population without stroke showed that NOTCH3 
variants were associated with the presence and progression of WMH35. Another study showed that only some 
of the NOTCH3 variants were associated with ischemic stroke in Chinese patients36. Therefore, most NOTCH3 
Figure 3. W-scores of cortical thickness patterns of the three groups (A) and comparison of the W-scores in 
the typical CADASIL group and the SVCI groups (B). (A) Cortical thinning areas in typical CADASIL patients, 
SVCI patients with NOTCH3 variants, and SVCI patients without NOTCH3 variants in reference to cognitively 
normal participants (W-score). (B-1) There is no significant difference in the W-scores of cortical thickness 
between the SVCI patients with NOTCH3 variants and the typical CADASIL patients. (B-2) SVCI patients 
without NOTCH3 variants showed lower W-scores of cortical thickness compared to typical CADASIL patients 
in the bilateral dorsolateral region, the medial prefrontal region, the occipital region, and the right anterior and 
left inferior temporal regions, suggesting that SVCI patients without NOTCH3 variants showed decreased cortical 
thickness compared to the typical CADASIL patients. CADASIL: cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy; SVCI: subcortical vascular cognitive impairment.
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variants do not seem to be associated with ischemic lesions, although there is a difference depending on race or 
type of polymorphism. Based on molecular genetics, CADASIL is caused by mutations in NOTCH3 that lead to 
an odd number of cysteine residues of epidermal growth factor repeats11. However, NOTCH3 variants did not 
affect WMH distribution or topography in our study because they do not involve a cysteine residue.
One strength of our study is that we performed multimodal neuroimaging analyses to investigate spatial fea-
tures among well-characterized cohorts of typical CADASIL patients and SVCI patients with genetic biomarker 
data. However, our study also had several limitations. First, an inevitable age gap was present between the typical 
CADASIL and the SVCI groups. Although we analyzed W-scores after controlling for age, the age difference could 
have affected the microstructural changes and cortical thinning. This argument is mitigated to some degree by the 
sensitivity analysis comparison, which showed that the two groups with similar ages had similar results. Second, 
the sample sizes of the typical CADASIL group and the SVCI with NOTCH3 variants group were small. Despite 
this limitation, we identified different neuroimaging features of typical CADASIL patients and SVCI patients by 
directly comparing these two groups.
In conclusion, SVCI patients and typical CADASIL patients showed distinct anatomic vulnerabilities of the 
grey matter and white matter structures. In contrast, no significant differences were observed between SVCI 
patients with NOTCH3 variants and SVCI patients without NOTCH3 variants. Therefore, our findings suggest 
that SVCI patients have different pathophysiology compared to typical CADSIL patients. Postmortem studies 
could help shed light on the reasons for these different involvement patterns.
Methods
Subjects. We recruited 11 patients with typical CADASIL and 116 patients with SVCI. The patients with 
typical CADASIL met the criteria for probable CADASIL, with some modifications37. The inclusion criteria were: 
extensive leukoaraiosis on brain MRI and at least one of the following: young age (<50) at onset of stroke or cog-
nitive decline or a family history of stroke or dementia suggesting autosomal dominant inheritance. In all cases, 
diagnosis was confirmed by identification of a typical mutation in the NOTCH3 gene. To be diagnosed with SVCI, 
patients had to meet the following criteria: (1) a subjective cognitive complaint by the patient or caregiver; (2) an 
objective cognitive impairment below the 16th percentile in any domain on neuropsychological tests; (3) signif-
icant ischemia on brain MRI, defined as periventricular WMH ≥ 10 mm and deep WMH ≥ 25 mm as modified 
from the Fazekas ischemia criteria24,38; and (4) focal neurologic symptoms or signs. In our previous study, 16 of 
the 117 (13.7%) patients with SVCI had NOTCH3 variants23, although these patients did not meet the probable 
CADASIL criteria proposed by Davous et al.37. A known pathogenic mutation was identified in 10 patients with 
SVCI, and variants of unknown significance (VUS) were identified in 6 patients with SVCI.
All SVCI patients completed a standardized [11C] PiB-PET scan at Samsung Medical Center using a 
Discovery STE PET/CT scanner (GE Medical Systems, Milwaukee, WI, USA). The detailed radiochemistry pro-
files, scanning protocol, and data analysis methods are described below. The specific radioactivity of 11C-PiB at 
the time of administration was more than 1,500 Ci/mmol for patients, and the radiochemical yield was more than 
35%. The radiochemical purity of the tracer was more than >95% in all PET studies. The 11C-PiB was injected 
into an antecubital vein as a bolus with a mean dose of 420 MBq (i.e., range 259–550 MBq). A CT scan was per-
formed for attenuation correction at 60 minutes after the injection. A 30-minute emission static PET scan was 
then initiated. We calculated the PiB uptake ratio of each voxel using the cerebellum as a reference region in the 
analysis. The global cortical PiB uptake ratio was determined by combining the bilateral frontal, parietal, and tem-
poral cortices and the posterior cingulate gyrus except the primary motor or sensory cortex. We did not perform 
partial volume correction. Patients were considered PiB-positive if their global PiB uptake ratio was more than 
>1.5 (Supplementary Fig. 6)24.
We also recruited 56 cognitively normal participants who had no history of neurologic or psychiatric illnesses 
and no abnormalities detected during neurological examination. They were classified to be cognitively normal 
by neuropsychological testing. All cognitively normal participants had no or mild WMH (periventricular WMH 
<10 mm and deep WMH <10 mm in maximal diameter) on MRI.
We excluded patients with territorial infarctions and those with high signal abnormalities on MRI due to radi-
ation injury, multiple sclerosis, vasculitis, or leukodystrophy. All patients completed a clinical interview and neu-
rological examination, as described previously24. Additionally, one typical CADASIL patient, two SVCI patients 
with NOTCH3 variants, and three SVCI patients without NOTCH3 variants were excluded due to MRI preproc-
essing errors. Therefore, the final set of participants analyzed consisted of 10 typical CADASIL patients, 13 SVCI 
patients with NOTCH3 variants, and 98 SVCI patients without NOTCH3 variants.
Standard protocol approvals, registrations, and patient consents. We obtained written informed 
consent from each participant. This study was approved by the Institutional Review Board at Samsung Medical 
Center. In addition, all methods were carried out in accordance with the approved guidelines.
Molecular genetic analysis. Peripheral blood specimens were collected after informed consent was 
obtained. Genomic DNA (gDNA) was extracted using a Wizard Genomic DNA Purification Kit according to the 
manufacturer’s instructions (Promega, Madison, WI, USA). Mutational hotspots of the NOTCH3 gene, including 
exons 2–6, 8, 11, 18, 19, and 22, were sequenced. Cycle sequencing was performed with a BigDye Terminator Cycle 
Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA) on an ABI 3130xl Genetic Analyzer 
(Applied Biosystems). As described in our previous study, we amplified the tested exons in the NOTCH3 gene and 
their exon-intron boundaries by polymerase chain reaction, after which we numbered the NOTCH3 cDNA nucleo-
tides according to a reference sequence39, GenBank accession number NM_000435.2. The Sorting Intolerant From 
Tolerant (SIFT)40 and the Polymorphism Phenotyping (PolyPhen-2 v2.1)41 servers were used to predict the effects 
of nonsynonymous VUS on protein structure, function, phenotype, and/or sequence conservation.
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MRI data acquisition. MRI was performed using a 3.0-Tesla MRI scanner (Achieva; Philips Medical 
Systems, Best, The Netherlands) at Samsung Medical Center. Standardized T2, 3D T1 turbo field echo, 3D 
fluid-attenuated inversion recovery (fluid-attenuated inversion recovery [FLAIR]), and DTI images were 
acquired from all applicable participants. Three-dimensional (3D) T1 Turbo Field Echo was acquired using the 
following imaging parameters: sagittal slice thickness, 1.0 mm, over contiguous slices with 50% overlap; no gap; 
repetition time34, 9.9 ms; echo time (TE), 4.6 ms; flip angle, 8°; and matrix size, 240 × 240 pixels, reconstructed to 
480 × 480 over a field of view (FOV) of 240 mm. The following parameters were used for the 3D FLAIR images: 
axial slice thickness of 2 mm; no gap; TR of 11,000 msec; TE of 125 msec; flip angle of 90°; and matrix size of 
512 × 512 pixels. In whole-brain DT-MRI examination, sets of axial diffusion-weighted single-shot echo-planar 
images were collected with the following parameters: 128 × 128 acquisition matrix, 1.72 × 1.72 × 2 mm3 voxel 
size; 70 axial slices; 22 × 22 cm2 field of view; TE 60 ms, TR 7,696 ms; flip angle 90°; slice gap 0 mm; b-factor of 
600 smm−2. Diffusion-weighted images were acquired in 45 different directions using the baseline image without 
weighting [0, 0, 0]. All axial sections were acquired parallel to the anterior commissure-posterior commissure. 
Reproducibility scans were not performed in this study.
WMH data analysis. A mask of regional WMH was quantified using a pre-developed automated pipeline 
as previously described42. Briefly, candidate WMH (i.e., region with high intensity compared to normal white 
matter regions) was extracted in the FLAIR image using the FMRIB Automatic Segmentation Tool. To eliminate 
misclassified regions, the candidate WMH was transformed to the T1-weighted MRI image using the transfor-
mation matrix of the affine registration from FLAIR to T1-weighted MRI. Next, the misclassified regions in the 
candidate WMH were removed by considering the white matter mask acquired from T1-weighted MRI. Thus, the 
final WMH result was extracted from the T1-weighted MRI space.
Tract-based spatial statistics (TBSS) analysis of DTI data. DTI is a neuroimaging technique that 
makes it possible to map microstructural changes of white matter in the brain43. FA and MD are common DTI 
measures. FA is a measure of white matter integrity, and MD is sensitive to cellularity, edema, and necrosis. 
DTI data were processed using software in the FMRIB Software Library (http://www.fmrib.ox.ac.uk/fsl). 
Motion artifacts and eddy current distortions were corrected by normalizing each diffusion-weighted volume 
to the non-diffusion-weighted volume (b0) using the affine registration method in the FMRIB’s Linear Image 
Registration Tool (FLIRT). Diffusion tensor matrices from the sets of diffusion-weighted images were generated 
using a general linear fitting algorithm. Subsequently, FA and MD were calculated for every voxel according to 
standard methods. The FA and MD maps of the DTI preprocessing results were used in TBSS analysis44. All FA 
images were aligned onto a standard FMRIB58 FA template provided by the FSL software, using a nonlinear reg-
istration algorithm implemented in the TBSS package. The FA images aligned on the FMRIB 58 FA template were 
averaged to create a skeletonized mean FA image. Each subject’s aligned FA image was projected onto the skele-
ton, filling it with the highest FA values from the nearest relevant center of the fiber tracts. A threshold FA value of 
0.2 was chosen to exclude voxels of adjacent gray matter or cerebrospinal fluid. MD images were also processed by 
applying the FA non-linear registration and projecting them onto the skeleton using identical projection methods 
to those inferred from the original FA data.
Cortical thickness analysis. The CIVET anatomical pipeline was used to extract cortical thickness (http://
mcin-cnim.ca/neuroimagingtechnologies/civet/)45. In brief, surfaces of the inner and outer cortices were gen-
erated for each hemisphere after correction for intensity non-uniformity, normalization to the MNI 152 tem-
plate, removal of non-brain tissues, and tissue classification of white matter, gray matter, cerebrospinal fluid, and 
background46–50. The presence of extensive WMH in the MRI scans made it difficult to completely delineate the 
inner cortical surface with the correct topology due to tissue classification errors. To overcome this technical 
limitation, we automatically defined the WMH region using a FLAIR image and substituted it for the intensity of 
peripheral, normal-appearing tissue on the high-resolution T1 image after affine co-registration, as described in 
earlier studies42. Cortical thickness was measured as the Euclidean distance between linked vertices of the inner 
and outer surfaces that contained 40,962 vertices on each hemisphere in native space51. To compare thickness 
across subjects, the thicknesses were spatially registered to a group template52,53 and smoothed with a full-width 
half-maximum of 20 mm51. Intracranial volume (ICV) was calculated by measuring the total volume of gray 
matter, white matter, and cerebrospinal fluid. Further image processing steps for cortical thickness have been 
described in previous studies54–57.
Construction of the W-score map. A limitation of this study was the marked age difference in the patient 
cohorts, which reflects the known difference in clinical and radiologic courses between typical CADASIL patients 
and SVCI patients. Therefore, we constructed W-score maps to quantitate the degree of WM microstructural 
changes and cortical atrophy in each patient using DTI measures (i.e., FA, MD) and cortical thickness, based 
on the cognitively normal participants group as a reference. The W-score concept and computation thereof are 
described in detail in a previous study58. In this study, W-score maps were computed vertex-wise on the surface 
model and voxel-wise on the skeletonized volume of each imaging data set as follows:
− =
′ − ′patient s raw value value expected in the control group for the patient s age sex and ICV
SD of the residuals in controls
W score [( ) ( , , )]
W-scores are similar to Z-scores, which have a mean value of 0 and an SD of 1 in cognitively normal partici-
pants; values of +1.65 and −1.65 correspond to the 95th and 5th percentiles, respectively. However, W-scores are 
adjusted for specific covariates such as age, sex, and ICV. To avoid confusion with respect to W-score direction in 
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cortical thickness and DTI measures, we used the W-scores as positive values indicating larger cortical thickness, 
larger values of FA, and large values of MD59.
Statistics. We examined the normality of the W-scores using a Kolmogorov-Smirnov test. We found that the 
W-score of mean cortical thickness, mean FA values, and mean MD values satisfied normality (p = 0.076~0.200). 
The difference in variability of W-score between groups was tested with Bartlett’s test for equality of variances. 
There was no difference in variability of mean cortical thickness values (p = 0.0756), mean FA values (p = 0.060), 
and mean MD values (p = 0.086). A value of p < 0.05 (two-sided) was considered statistically significant.
WMH, global mean DTI W-scores, and cortical thickness data were compared between patient groups by 
ANCOVA, after the data were adjusted for age and sex, with the Bonferroni post hoc test. To examine the local 
degrees of atrophy, individual W-score maps were averaged in each patient group. Differences in W-scores at each 
vertex and each skeletonized voxel following contrast were compared between the following groups: (1) SVCI 
without NOTCH3 variants vs. SVCI with NOTCH3 variants; (2) typical CADASIL vs. SVCI without NOTCH3 
variants; and (3) typical CADASIL vs. SVCI with NOTCH3 variants. Multiple comparisons were corrected by 
FDR for cortical thickness or by FWE for microstructural changes (p < 0.05). FWE and FDR are methods of con-
ducting multiple comparison correction. Statistical analyses were implemented using the SurfStat toolbox (http://
www.math.mcgill.ca/keith/surfstat/), MATLAB (R2012a, The MathWorks, Inc., Natick, MA) and the Randomise 
function (part of FSL). The resulting t-value and p-value maps were projected on an ICBM 152 surface template 
and a volume template for visualization. Additionally, subgroup analysis was performed for the amyloid-negative 
group to rule out potential effects of amyloid deposition on cortical thickness.
Data Availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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